{"id":"W2095011021","doi":"10.1080/14660820410019602","title":"Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials","year":2004,"lang":"en","type":"article","venue":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders","topic":"Synthetic Organic Chemistry Methods","field":"Chemistry","cited_by":130,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"Sanofi","keywords":"Amyotrophic lateral sclerosis; Medicine; Riluzole; Tolerability; Placebo; Hazard ratio; Internal medicine; Regimen; Confidence interval; Clinical endpoint; Relative risk; Randomized controlled trial; Adverse effect; Anesthesia; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008285498,0.0005116111,0.001248212,0.0001307925,0.00008884317,0.00005210339,0.000349366,0.0002264631,0.000290287],"category_scores_gemma":[0.0003784232,0.0004501553,0.0002203006,0.000276018,0.0004804014,0.0001440927,0.0001752712,0.000339272,0.000001940835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006712294,"about_ca_system_score_gemma":0.00005710617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001623939,"about_ca_topic_score_gemma":0.000065981,"domain_scores_codex":[0.996254,0.0002592486,0.001680912,0.0008749267,0.0003953532,0.0005356186],"domain_scores_gemma":[0.9979868,0.0003713258,0.0007060566,0.000687149,0.00004460559,0.0002040881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004204295,0.0006543947,0.001792006,0.0001687224,0.0001043798,0.000003364906,0.0008335171,0.0001235623,0.9815876,0.00005614581,0.00001410016,0.01045784],"study_design_scores_gemma":[0.2282156,0.001420191,0.1415204,0.00367929,0.0005402602,0.00002958599,0.0002416982,0.0005440778,0.6172948,0.002705938,0.00178087,0.002027305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972009,0.0007042227,0.00002026213,0.0008671132,0.0001079279,0.0004423772,0.0002577042,0.00006283898,0.0003366187],"genre_scores_gemma":[0.9973295,0.001619607,0.000538678,0.000194432,0.00008721231,0.00003198357,0.00001286441,0.0001001963,0.00008557707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3642929,"threshold_uncertainty_score":0.999795,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04204555025741296,"score_gpt":0.2973084749759468,"score_spread":0.2552629247185338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}